Save the date for our a spring investor open house. The event will be held Tuesday, May 15 from 5:00 - 7:30 PM. We look forward to seeing you and sharing the exciting progress of our portfolio companies.
MINNEAPOLIS, January 24, 2017 – Venture catalyst Invenshure announces the move of its corporate offices from the Warehouse District in Northeast Minneapolis. The company now occupies the entire SW corner of the 3rd floor of the Highlight Center building off Broadway. Buildout began last September (2016) and the move was completed in early December.
MINNEAPOLIS, Jan. 20, 2016 – Venture catalyst Invenshure announces the establishment of its new office location in Boston, Massachusetts. This new location will function as a strategic business development office, which will allow Invenshure to develop partnerships and to research new technologies and industries on the East Coast.
MINNEAPOLIS, Minn. – Venture catalyst Invenshure announces the adoption of Evidentia Health, Inc., a company that develops innovative Enhanced Diagnostic Reports for radiology, pathology, and other specialties.
The partnership provides capital and resources to further develop Evidentia’s technology, bringing patients and referring physicians context-relevant patient education, evidence-based research and novel communication tools embedded directly in personalized reports.
MINNEAPOLIS, Minn. – Venture catalyst Invenshure announces the launch of Tychon Biosciences, a biotechnology company commercializing adaptive immunotherapy technology developed in the laboratory of Dr. Carston (Rick) Wagner at the University of Minnesota.